Teva (TEVA) Receives FDA Approval for CML Treatment Synribo
Go back to Teva (TEVA) Receives FDA Approval for CML Treatment Synribo| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 37.44 +0.86 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.58 | 52 Week High | $66.55 | |||
| Open | $37.00 | 52 Week Low | $37.82 | |||
| Day High | $37.83 | P/E | N/A | |||
| Day Low | $36.60 | EPS | $0.00 | |||
| Volume | 5,260,422 | |||||
